News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-11 1:6:36 pm SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024 GlobeNewsWire
2024-03-05 7:44:10 pm Q4 2023 Nuwellis Inc Earnings Call Thomson Reuters StreetEvents
2024-02-27 5:30:0 am Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure GlobeNewswire
2024-02-22 4:58:0 am Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™ GlobeNewswire
2024-02-22 4:53:0 am FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury GlobeNewswire
2024-02-22 3:15:0 am Unleash Massive Returns With These 3 Top Penny Stocks InvestorPlace
2024-02-01 5:30:0 am SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology GlobeNewswire
2024-01-26 5:5:0 am SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire
2024-01-11 1:5:0 pm SeaStar Medical Appoints David A. Green as Chief Financial Officer GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information